Purchases and Sales Made in Q4 2023 in Pharvaris N.V. (PHVS)
This table provides information about the institutional ownership of Pharvaris N.V. (PHVS) during Q4 2023. The information is specifically focused on institutions that hold shares of Pharvaris N.V..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
1.83M+ 117.18% |
$27.8M - $51.4M
|
3.4M
$62.8M
|
|
Feb 13, 2024
Q4 2023
|
General Atlantic LLC
New York, NY |
BUY
|
- |
1.75M+ 39.72% |
$26.6M - $49.1M
|
6.16M
$114M
|
|
Feb 14, 2024
Q4 2023
|
Eco R1 Capital, LLC
San Francisco, CA |
BUY
|
- |
900KNew |
$13.7M - $25.2M
|
900K
$16.7M
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
BUY
|
- |
843KNew |
$12.8M - $23.6M
|
843K
$15.6M
|
|
Feb 14, 2024
Q4 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
BUY
|
- |
812KNew |
$12.3M - $22.8M
|
812K
$15M
|
|
Feb 14, 2024
Q4 2023
|
Commodore Capital LP
New York, NY |
BUY
|
- |
800KNew |
$12.2M - $22.4M
|
800K
$14.8M
|
|
Feb 14, 2024
Q4 2023
|
Ven Bio Partners LLC
San Francisco, CA |
BUY
|
- |
655K+ 15.35% |
$9.95M - $18.4M
|
4.92M
$91M
|
|
Feb 12, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
BUY
|
- |
510KNew |
$7.76M - $14.3M
|
510K
$9.44M
|
|
Feb 14, 2024
Q4 2023
|
Viking Global Investors LP
|
BUY
|
- |
425K+ 13.15% |
$6.46M - $11.9M
|
3.66M
$67.7M
|
|
Feb 14, 2024
Q4 2023
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
350K+ 25.71% |
$5.32M - $9.82M
|
1.71M
$31.7M
|
|
Feb 13, 2024
Q4 2023
|
Foresite Capital Management Iv, LLC
Larkspur, CA |
BUY
|
- |
295K+ 7.89% |
$4.49M - $8.29M
|
4.04M
$74.7M
|
|
Feb 06, 2024
Q4 2023
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
285KNew |
$4.33M - $7.99M
|
285K
$5.27M
|
|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
245KNew |
$3.72M - $6.87M
|
245K
$4.53M
|
|
Feb 14, 2024
Q4 2023
|
Novo Holdings
Hellerup, G7 |
BUY
|
- |
210K+ 15.8% |
$3.19M - $5.89M
|
1.54M
$28.5M
|
|
Feb 14, 2024
Q4 2023
|
5 Am Venture Management, LLC
San Francisco, CA |
BUY
|
- |
210K+ 35.74% |
$3.19M - $5.89M
|
798K
$14.8M
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
189KNew |
$2.87M - $5.29M
|
189K
$3.49M
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
141KNew |
$2.15M - $3.97M
|
141K
$2.62M
|
|
Feb 14, 2024
Q4 2023
|
Blackstone Inc
New York, NY |
BUY
|
- |
100KNew |
$1.52M - $2.81M
|
100K
$1.85M
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
60.1KNew |
$914K - $1.69M
|
60.1K
$1.11M
|
|
Feb 13, 2024
Q4 2023
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
BUY
|
- |
55.1KNew |
$837K - $1.54M
|
55.1K
$1.02M
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
BUY
|
- |
31.2K+ 80.33% |
$475K - $876K
|
70.1K
$1.3M
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
29.7K+ 1153.12% |
$452K - $834K
|
32.3K
$598K
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
- |
18KNew |
$274K - $505K
|
18K
$333K
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
8.55KNew |
$130K - $240K
|
8.55K
$158K
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
8.2KNew |
$125K - $230K
|
8.2K
$152K
|
|
Feb 14, 2024
Q4 2023
|
Quarry LP
New York, NY |
BUY
|
- |
750New |
$11.4K - $21K
|
750
$13.9K
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
500+ 4.2% |
$7.6K - $14K
|
12.4K
$229K
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
190New |
$2.89K - $5.33K
|
190
$3.52K
|
|
Feb 12, 2024
Q4 2023
|
Piper Sandler & Co.
Minneapolis, MN |
BUY
|
- |
181New |
$2.75K - $5.08K
|
181
$3.35K
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-808- 3.47% |
$12.3K - $22.7K
|
22.5K
$416K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-3.15K- 3.88% |
$47.8K - $88.3K
|
77.9K
$1.44M
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-11.2K- 33.26% |
$170K - $314K
|
22.5K
$416K
|
|
Aug 15, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-91.1K- 15.14% |
$1.38M - $2.56M
|
510K
$9.44M
|
|
Feb 14, 2024
Q4 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-127K- 36.8% |
$1.92M - $3.55M
|
217K
$4.02M
|
|
Feb 13, 2024
Q4 2023
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-964K- 19.81% |
$14.7M - $27.1M
|
3.9M
$72.2M
|